These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 2965032)
1. Histologic evaluation of the luteal phase in women following follicle aspiration for oocyte retrieval. Graf MJ; Reyniak JV; Battle-Mutter P; Laufer N Fertil Steril; 1988 Apr; 49(4):616-9. PubMed ID: 2965032 [TBL] [Abstract][Full Text] [Related]
2. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment. Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285 [TBL] [Abstract][Full Text] [Related]
3. Steroid receptor expression in late follicular phase endometrium in GnRH antagonist IVF cycles is already altered, indicating initiation of early luteal phase transformation in the absence of secretory changes. Papanikolaou EG; Bourgain C; Kolibianakis E; Tournaye H; Devroey P Hum Reprod; 2005 Jun; 20(6):1541-7. PubMed ID: 15705618 [TBL] [Abstract][Full Text] [Related]
4. Administration of human luteinizing hormone (hLH) to macaques after follicular development: further titration of LH surge requirements for ovulatory changes in primate follicles. Zelinski-Wooten MB; Hutchison JS; Chandrasekher YA; Wolf DP; Stouffer RL J Clin Endocrinol Metab; 1992 Aug; 75(2):502-7. PubMed ID: 1639951 [TBL] [Abstract][Full Text] [Related]
5. Early luteal phase endocrine profile is affected by the mode of triggering final oocyte maturation and the luteal phase support used in recombinant follicle-stimulating hormone-gonadotropin-releasing hormone antagonist in vitro fertilization cycles. Fatemi HM; Polyzos NP; van Vaerenbergh I; Bourgain C; Blockeel C; Alsbjerg B; Papanikolaou EG; Humaidan P Fertil Steril; 2013 Sep; 100(3):742-7. PubMed ID: 23806846 [TBL] [Abstract][Full Text] [Related]
6. Histological evaluation of endometrium on the day of oocyte retrieval after gonadotrophin-releasing hormone agonist-follicle stimulating hormone ovulation induction for in-vitro fertilization. Lass A; Peat D; Avery S; Brinsden P Hum Reprod; 1998 Nov; 13(11):3203-5. PubMed ID: 9853881 [TBL] [Abstract][Full Text] [Related]
7. Delaying human chorionic gonadotropin administration in human menopausal gonadotropin-induced cycles decreases successful in vitro fertilization of human oocytes. Laufer N; DeCherney AH; Tarlatzis BC; Zuckerman AL; Polan ML; Dlugi AM; Graebe R; Barnea ER; Naftolin F Fertil Steril; 1984 Aug; 42(2):198-203. PubMed ID: 6430722 [TBL] [Abstract][Full Text] [Related]
8. 1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled study. Humaidan P; Ejdrup Bredkjaer H; Westergaard LG; Yding Andersen C Fertil Steril; 2010 Feb; 93(3):847-54. PubMed ID: 19200959 [TBL] [Abstract][Full Text] [Related]
9. [Hormone profile and follicle development in ovarian stimulation treatment for in vitro fertilization. II. Prolactin, estradiol and progesterone profile]. Sudik R; Fliess FR; Kunkel S Zentralbl Gynakol; 1989; 111(9):567-80. PubMed ID: 2500795 [TBL] [Abstract][Full Text] [Related]
10. Impact of clomiphene citrate during ovarian stimulation on the luteal phase after GnRH agonist trigger. Derksen L; Tournaye H; Stoop D; Van Vaerenbergh I; Bourgain C; Polyzos NP; Haentjens P; Blockeel C Reprod Biomed Online; 2014 Mar; 28(3):359-68. PubMed ID: 24456700 [TBL] [Abstract][Full Text] [Related]
11. Accelerated endometrial maturation in the luteal phase of cycles utilizing controlled ovarian hyperstimulation: impact of gonadotropin-releasing hormone agonists versus antagonists. Saadat P; Boostanfar R; Slater CC; Tourgeman DE; Stanczyk FZ; Paulson RJ Fertil Steril; 2004 Jul; 82(1):167-71. PubMed ID: 15237007 [TBL] [Abstract][Full Text] [Related]
12. In vitro fertilization and embryo transfer as related to endogenous luteinizing hormone rise or human chorionic gonadotropin administration. Lejeune B; Degueldre M; Camus M; Vekemans M; Opsomer L; Leroy F Fertil Steril; 1986 Mar; 45(3):377-83. PubMed ID: 3949037 [TBL] [Abstract][Full Text] [Related]
13. Mifepristone is an effective oral alternative for the prevention of premature luteinizing hormone surges and/or premature luteinization in women undergoing controlled ovarian hyperstimulation for in vitro fertilization. Escudero EL; Boerrigter PJ; Bennink HJ; Epifanio R; Horcajadas JA; Olivennes F; Pellicer A; Simón C J Clin Endocrinol Metab; 2005 Apr; 90(4):2081-8. PubMed ID: 15483085 [TBL] [Abstract][Full Text] [Related]
14. Daily low-dose hCG stimulation during the luteal phase combined with GnRHa triggered IVF cycles without exogenous progesterone: a proof of concept trial. Andersen CY; Elbaek HO; Alsbjerg B; Laursen RJ; Povlsen BB; Thomsen L; Humaidan P Hum Reprod; 2015 Oct; 30(10):2387-95. PubMed ID: 26209535 [TBL] [Abstract][Full Text] [Related]
15. Luteal phase deficiency: characterization of reproductive hormones over the menstrual cycle. Soules MR; McLachlan RI; Ek M; Dahl KD; Cohen NL; Bremner WJ J Clin Endocrinol Metab; 1989 Oct; 69(4):804-12. PubMed ID: 2506214 [TBL] [Abstract][Full Text] [Related]
16. Sequential use of clomiphene citrate, human menopausal gonadotropin, and human chorionic gonadotropin in human in vitro fertilization. II. Study of luteal phase adequacy following aspiration of the preovulatory follicles. Cohen JJ; Debache C; Pigeau F; Mandelbaum J; Plachot M; de Brux J Fertil Steril; 1984 Sep; 42(3):360-5. PubMed ID: 6432585 [TBL] [Abstract][Full Text] [Related]
17. Endometrial gene expression in the early luteal phase is impacted by mode of triggering final oocyte maturation in recFSH stimulated and GnRH antagonist co-treated IVF cycles. Humaidan P; Van Vaerenbergh I; Bourgain C; Alsbjerg B; Blockeel C; Schuit F; Van Lommel L; Devroey P; Fatemi H Hum Reprod; 2012 Nov; 27(11):3259-72. PubMed ID: 22930004 [TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of low dose hCG for luteal support after triggering ovulation with a GnRH agonist in cases of polyfollicular development. Krause BT; Ohlinger R Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):87-92. PubMed ID: 16377065 [TBL] [Abstract][Full Text] [Related]
19. Suppression of luteal function by a luteinizing hormone-releasing hormone antagonist during the early luteal phase in the stumptailed macaque monkey and the effects of subsequent administration of human chorionic gonadotropin. Fraser HM; Nestor JJ; Vickery BH Endocrinology; 1987 Aug; 121(2):612-8. PubMed ID: 3109885 [TBL] [Abstract][Full Text] [Related]
20. The effect of the day of initiation of ovarian stimulation in the day of luteinizing hormone surge and outcome of in vitro fertilization. Mahadevan MM; Fleetham J; Taylor PJ; Leader A; Pattinson AH Fertil Steril; 1987 Jun; 47(6):976-9. PubMed ID: 3109959 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]